Evaluation of hormone receptor, human epidermal growth factor receptor‐2 and K i‐67 with core needle biopsy and neoadjuvant chemotherapy effects in breast cancer patients
Abstract Background We investigated the reliability of core needle biopsy ( CNB ) in evaluating the status of hormone receptor ( HR ), human epidermal growth factor receptor ( HER) ‐2, and K i‐67 status, and the effect of neoadjuvant chemotherapy ( NAC ) on the expression of these immunohistochemica...
Saved in:
Published in | Thoracic cancer Vol. 6; no. 1; pp. 64 - 69 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.01.2015
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Background
We investigated the reliability of core needle biopsy (
CNB
) in evaluating the status of hormone receptor (
HR
), human epidermal growth factor receptor (
HER)
‐2, and
K
i‐67 status, and the effect of neoadjuvant chemotherapy (
NAC
) on the expression of these immunohistochemical markers.
Methods
Among 177 patients with breast adenocarcinoma, 95 patients underwent
NAC
and the remaining 82 patients made up the control group. Immunohistochemistry (
IHC
) was used to evaluate the expression status of estrogen receptor (
ER
), progesterone receptor (
PR
),
HER
‐2, and
K
i‐67 in the specimens obtained by surgical excision or
CNB
.
Results
I
n the control group, the expression of
ER
,
PR
,
HER
‐2, and
K
i‐67 was highly consistent between samples from surgical excision or
CNB
(all
r
> 0.8,
P
< 0.05). In the
NAC
group, the proportions of samples with changes in
ER
,
PR
,
HER
‐2, and
K
i‐67 expression were 12.7%, 24.1%, 5.1%, and 38.0%, respectively; the figures in the control group were 2.4%, 4.9%, 2.4%, and 7.3%, respectively, which significantly differed in
ER
,
PR
, and
K
i‐67 (
P
< 0.05), but not
HER
‐2 (
P
> 0.05). In the
NAC
group, pre‐ and post‐treatment
ER
+
rates did not significantly differ (
P
> 0.05), although
PR
+
and high
K
i‐67 expression rates did significantly differ (
P
< 0.05).
Conclusion
Neither
CNB
nor surgical excision samples gave highly consistent results in
HR
,
HER
‐2, and
K
i‐67 status.
NAC
can alter
HR
and
K
i‐67 status in breast adenocarcinoma patients.
NAC
decreased
PR
+
rate and
K
i‐67 expression. The mean
ER
+
rate exhibited a decreasing, but insignificant trend after
NAC
treatment.
NAC
had no significant effect on
HER
‐2 expression. |
---|---|
ISSN: | 1759-7706 1759-7714 |
DOI: | 10.1111/1759-7714.12133 |